Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

From Pharma Insider To Payer: Witty To Lead United's Optum

Mar 13 2018

• By Jessica Merrill

Andrew Witty (GSK)

Related Content

GSK’s Witty Speaks Further On M&amp;A, Pricing

Jan 16 2009

Praluent Pricing: Collaboration With ICER Sets A New Standard

Mar 12 2018

New UK Pathway To Cut Access Times For Breakthrough Products By Up To Four Years

Nov 03 2017

GSK Reveals Big Changes As 2015 Growth Prospects Fizzle

Oct 27 2014

Industry Sounds Somewhat Muted Drug Pricing Alarm

Nov 03 2016

GSK’s New CEO Designate Walmsley Fortifies Volume Growth Strategy

Sep 20 2016

Related Companies

UnitedHealth Group

GSK plc

Express Scripts Holding Company

Medco Health Solutions Inc.

CVS Health Corp.

Sanofi

Regeneron Pharmaceuticals, Inc.

Additional Topics

Leadership Pricing Debate Market Access Commercial BioPharmaceutical

More from Leadership

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window